InspireMD/NSPR

$2.56

-2.64%
-
1D1W1MYTD1YMAX

About InspireMD

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Ticker

NSPR

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Marvin Slosman

Employees

56

Headquarters

Tel aviv-yafo, Israel

InspireMD Metrics

BasicAdvanced
$56.67M
Market cap
-
P/E ratio
-$1.52
EPS
0.84
Beta
-
Dividend rate

What the Analysts think about InspireMD

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
89.45% upside
High $5.20
Low $4.50
$2.56
Current price
$4.85
Average price target

InspireMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-340% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$1.5M
-6.25%
Net income
$-5.1M
2%
Profit margin
-340%
8.8%

InspireMD Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.23%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.63
-$0.56
-$0.25
-$0.16
-
Expected
-$0.88
-$0.71
-$0.32
-$0.16
-$0.20
Surprise
-28.57%
-22.06%
-20%
-3.23%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell InspireMD stock

Buy or sell InspireMD stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing